herpes
Autoantibodies to Type I Interferons Increase the Risk of Fulminant Hepatitis Caused by HSV
Therapeutic Opportunities With Interferons
Defects in the Type I Interferon Pathway Contribute to Immunopathology in Herpetic Encephalitis
NF-κB Blockade Reduces the Severity of Herpetic Encephalitis in Mice with the IRF3 R278Q Mutation
Shingles vaccination reduces dementia risk by 20%
A natural experiment among residents of Wales
Recombinant Shingles Vaccine Reduces Dementia Risk
17% Greater Effectiveness Compared to Live Vaccine
Epstein-Barr Virus Increases the Risk of Multiple Sclerosis by 32 Times
A 20-Year Study on American Servicemen
Genetic Roots of Severe Infections: From Coronavirus to EBV
Why Some Children Suffer More Severely
Properties and Antiviral Activity of Interferon Epsilon
IFN-ε may protect against HIV
Type I Interferon Protects against Hyperinflammation and Tissue Damage
Interferon inhibits the production of enzymes by macrophages that destroy tissue structure
Herpesvirus and Type III Interferon System
Interferon-λ suppresses replication of herpes simplex virus
Interferon- α2b in postherpetic neuralgia
High-frequency current combined with interferon-α2b injection successfully treats shingles neuralgia
Interferons and herpetic infections
The quality of life of a person who has the herpes virus depends on the interferon system's operation
Treating herpes locally: comparing combined and monotherapy
A combination of drugs affects different mechanisms of viruses’ reproduction. Monotherapy is strong with a higher concentration of the active substance